AngioDynamics Oncology Surgery Biz Helps Drive 13% Sales Growth
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics' sales advanced 13% to $50.1 million in the firm's most recent fiscal quarter, aided by strong growth in its Oncology/Surgery business, the firm reported Oct. 6